BCWORLD PHARM. Co., Ltd.

KOSDAQ 200780.KQ

BCWORLD PHARM. Co., Ltd. EBITDA Margin for the year ending December 31, 2023: 18.52%

BCWORLD PHARM. Co., Ltd. EBITDA Margin is 18.52% for the year ending December 31, 2023, a 41.25% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

BCWORLD PHARM. Co., Ltd. EBITDA Margin for the year ending December 31, 2022 was 13.11%, a 68.98% change year over year.
BCWORLD PHARM. Co., Ltd. EBITDA Margin for the year ending December 31, 2021 was 7.76%, a 7.29% change year over year.
BCWORLD PHARM. Co., Ltd. EBITDA Margin for the year ending December 31, 2020 was 7.23%, a 53.11% change year over year.
BCWORLD PHARM. Co., Ltd. EBITDA Margin for the year ending December 31, 2019 was 4.72%, a -71.62% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

KOSDAQ: 200780.KQ

BCWORLD PHARM. Co., Ltd.

CEO	Mr. Sung-Han Hong
IPO Date	Dec. 15, 2014
Location	South Korea
Headquarters	22 Geumto-ro 40beon-gil
Employees	284
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

BCWORLD PHARM. Co., Ltd. operates as a pharmaceutical company in South Korea. The company provides products in various therapeutic areas comprising musculoskeletal system, digestive system, circulatory machine, central nervous system, adrenocorticosteroids, narcotic analgesics, erectile dysfunction treatment, wellbeing injection, diuretic, antitussive expectorant, vaginitis treatment, anti-tuberculosis drugs, anti-emetic, antiviral drugs, antibiotic, anti-malignant tumor drugs, antifungal agent, antihistamines, antidote, and antipyretic/analgesic/anti-inflammatory. BCWORLD PHARM. Co., Ltd. was founded in 1980 and is headquartered in Seongnam-si, South Korea.

Key trends

Past 5 years